UPCC 02722 Mount Sinai Acute Graft-versus-Host Disease International Consortium (MAGIC): A Database and Biorepository

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to improve our understanding of graft-versus-host disease (GVHD) which is a complication that can occur after a bone marrow transplant. Investigators at Mount Sinai and other BMT centers around the world have formed a collaboration to share and study clinical data and blood samples in order to develop techniques that will allow GVHD to be predicted and identify the best treatments for GVHD.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 22-1306
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator